Glow Dosage Chart
Glow dosage chart — how to reconstitute the 70 mg blend, tiered subcutaneous protocols with per-component unit math, and the TB-500 accumulation caveat.
Save 15% with code VIALBASE
Save 15% with code VIALBASE
Save 15% with code VIALBASE
VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.
Reconstitution
70 mg Glow vial (GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg) in 2 mL bacteriostatic water
Reconstituted at 70 mg / 2 mL, the blend is 35 mg/mL. On a U-100 syringe, 10 units = 0.1 mL = 3.5 mg of blend; GHK-Cu sits at 25 mg/mL, BPC-157 and TB-500 at 5 mg/mL each.
The Glow dosage chart covers how to reconstitute the 70 mg blend and the tiered subcutaneous protocols below, with the per-component milligram math for each draw. Glow is a fixed-ratio blend — you titrate the vial, not the individual peptides — so the tiers move the whole blend up or down together.
Dosage protocols
Starter (titration)
- GHK-Cu 2.5 mg
- BPC-157 500 mcg
- TB-500 500 mcg
Start low to gauge tolerance before the standard draw. 10 units delivers BPC-157 and TB-500 at 500 mcg each — in range for their typical standalone doses — with 2.5 mg of GHK-Cu.
Standard (daily)
- GHK-Cu 5 mg
- BPC-157 1 mg
- TB-500 1 mg
The common maintenance draw. 20 units puts GHK-Cu at 5 mg and the repair peptides at 1 mg each. One 2 mL vial lasts ~10 days at this tier.
TB-500-moderated cadence
- GHK-Cu 5 mg / dose
- BPC-157 1 mg / dose
- TB-500 1 mg / dose
Because TB-500 has a ~14-day half-life, daily blend dosing accumulates more TB-500 than a typical 2–5 mg/week standalone schedule. Dosing every other day moderates cumulative TB-500 while keeping the shorter-half-life components (GHK-Cu, BPC-157) effective.
Your vial, your numbers
Different vial size or water volume? Recalculate your exact draw.
Glow blend
Draw to mark
20u(0.200 mL)
Concentration
35000 mcg / mL
For research purposes only. Verify all calculations independently before use.
From vial to injection
- Sanitize Wipe the vial stopper and the bacteriostatic-water vial stopper with fresh alcohol swabs and let them dry.
- Draw the diluent Draw 2 mL of bacteriostatic water into a reconstitution syringe.
- Add water slowly Insert the needle at an angle and let the water run down the inside wall of the peptide vial — do not spray it directly onto the powder.
- Swirl, don't shake Gently swirl or roll the vial until fully dissolved. Never shake — agitation can degrade the peptides.
- Draw your dose With a U-100 insulin syringe, draw to the unit mark for your tier (10 units = 0.1 mL, 20 units = 0.2 mL).
- Inject subcutaneously Inject into subcutaneous fat (abdomen or flank), rotating sites. Store the reconstituted vial at 2–8 °C and use within 28 days.
Feeling something? Check here
- Mild, transient injection-site redness, itch or a small welt that fades within an hour
- A brief flushing or warmth after the copper-peptide component
- Temporary fatigue in the first few days as you titrate
- Persistent headache, lightheadedness or nausea that doesn't settle — back off to the starter draw and reassess
- Injection-site lumps, swelling or bruising that linger more than a day — rotate sites and check technique
- Chest tightness, difficulty breathing, or facial/throat swelling — stop immediately and seek emergency care (possible allergic reaction)
- Signs of infection at an injection site — spreading redness, heat, pus, fever
- Any new or growing lump elsewhere — peptides that drive tissue growth are contraindicated with active or suspected cancer
General subcutaneous-peptide safety guidance; TB-500 tolerability anchored to a phase-1 thymosin β4 trial (54 healthy volunteers, 0.05–25 mcg/kg IV, mild-to-moderate adverse events, no dose-limiting toxicity).
This self-check is educational, not a diagnosis. When in doubt, stop dosing and consult a qualified healthcare provider.